Smith & Nephew PLC (SN) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Total Assets Chart for Smith & Nephew PLC
Smith & Nephew PLC (SN) total assets for FY2025 were GBP 10.5B, a 1.0% change from FY2024. Smith & Nephew PLC's total assets grew from GBP 643.4M in 1985 to GBP 10.5B in 2025 (1525.9% over 40 years). Total assets compound annual growth rate: 5-year CAGR of -1.0%, 10-year CAGR of 3.9%, 20-year CAGR of 6.5%.
Total Assets (British Pounds)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- £8.92B
- Implied Share Price
- £10.66
- Enterprise Value
- £11.16B
- Revenue (TTM)
- £6.30B
- EBITDA
- £1.38B
- Profit Margin
- 10.08%
- Trailing P/E
- 19.73
- Forward P/E
- 13.09
- Price/Book (MRQ)
- 2.35
- Price/Sales (TTM)
- 1.42
- EV/EBITDA
- 9.68
- EV/Revenue
- 2.42
- Dividend Yield
- 3.71%
- Book Value
- £4.50
- Free Cash Flow (FY2025)
- £869.88M
- Free Cash Flow Yield
- 9.75%
Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.